Pricing

ChromaDex Corp (CDXC)

followers ·
Sector:
INDUSTRIALS
Industry:
COMMERCIAL SERVICES & SUPPLIES
SIC:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
CEO:
Robert N. Fried
Employees:
120
10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
310-388-6706
    Formally known as:
  • ChromaDex Corp.
Stock Split History
DateRatio
2008-03-28 11538461:1
2016-04-13 1:3
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. It researches on nicotinamide adenine dinucleotide (NAD+) and develops and commercializes proprietary-based ingredient technologies. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available